- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 15/12 - Drugs for genital or sexual disordersContraceptives for climacteric disorders
Patent holdings for IPC class A61P 15/12
Total number of patents in this class: 252
10-year publication summary
|
5
|
7
|
12
|
13
|
27
|
17
|
26
|
12
|
17
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2722 |
10 |
| Estetra SRL | 107 |
7 |
| Solarea bio, Inc. | 37 |
6 |
| Bonafide Health, LLC | 117 |
6 |
| Janssen Pharmaceutica N.V. | 3298 |
5 |
| Bayer Schering Pharma AG | 355 |
5 |
| Kao Corporation | 5030 |
5 |
| Endorecherche, Inc. | 21 |
3 |
| Meiji Co., Ltd. | 734 |
3 |
| Natreon, Inc. | 46 |
3 |
| Otsuka Pharmaceutical Co., Ltd. | 1502 |
3 |
| Pep-Tonic Medical AB | 12 |
3 |
| Shiseido Company, Ltd. | 4199 |
3 |
| Kallyope, Inc. | 60 |
3 |
| Acebiome Inc. | 13 |
3 |
| KaNDy Therapeutics Limited | 17 |
3 |
| SPH Sine Pharmaceutical Laboratories Co., Ltd | 16 |
3 |
| Boehringer Ingelheim International GmbH | 4576 |
2 |
| Boehringer Ingelheim Pharma GmbH & Co. Kg | 457 |
2 |
| Bayer Intellectual Property GmbH | 2437 |
2 |
| Other owners | 172 |